Download presentation
Presentation is loading. Please wait.
1
Cholangiocarcinoma Tamar Taddei, MD
2
Key Points PSC is a risk factor for developing cholangiocarcinoma (CCA) Screening is controversial Remaining in close contact and having routine visits with your healthcare team is essential to early diagnosis Stress is unproductive A healthy lifestyle is key to most preventive medicine
3
Definition Cholangiocarcinoma (CCA) and bile duct cancer are the same thing In general the incidence of CCA is on the rise This is a primary liver cancer that arises in the biliary cells (cholangiocytes) of the liver
4
Causes The pathogenesis of CCA is linked to bile stasis, inflammation, periductal fibrosis, and hyperplasia 1/256 patients with UC Lifetime risk 10-15% in PSC Cumulative risk of CCA is 11.2% at 10 years after diagnosis ( % per year)
5
Causes Other important risk factors Liver fluke
Intrahepatic gallstones Choledochal cysts (Caroli’s disease) Exposures (thorotrast)
6
https://www. jhmicall. org/GDL_Disease. aspx
7
Diagnosis Laboratory tests Imaging/endoscopic tests Sampling
CEA, CA 19-9, AFP (positive in < 50%, but at late stage) Imaging/endoscopic tests US MRI EUS (also very helpful for staging) ERCP Sampling Brushings may be of low yield
8
A Helpful Schematic Rizvi S and Gores GJ, Hepatology :1356.
9
Understanding Liver Anatomy
10
Treatment: Curative Where is the tumor? Is it surgically resectable?
Bilateral hepticojejunostomy with Roux-en-Y anastomosis Unilateral hepticojejunostomy with Roux-en-Y anastomosis and left hepatectomy
11
Treatment: Curative Where is the tumor? Is it surgically resectable?
Percent resectable ▪ Intrahepatic (peripheral): 50% ▪ Perihilar: 56% ▪ Distal: 91% 5 year survival ▪ Intrahepatic (peripheral): 44% (26 mos) ▪ Perihilar: 11% (19 mos) ▪ Distal: 28% (22 mos) Whipple with hepatojejunostomy, duodenojejunoscopy, and pancreaticojejunostomy
12
Treatment: Palliative
Treating cholestasis/jaundice (biliary stents) Improves fatigue, diarrhea, anorexia, pruritus, jaundice, sleep pattern Prevents cholangitis Decrease tumor growth rates Chemotherapy Radiotherapy Photodynamic therapy
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.